Crinetics Pharmaceuticals, Inc. (CRNX) › RevenueCrinetics Pharmaceuticals, Inc. (CRNX) — RevenueAnnual figures by fiscal year, from SEC filings.2016: $589.0K2017: $2.04M2018: $2.43M2019: $1.19M2020: $71.0K2021: $02022: $02023: $4.01M2024: $1.04M2025: $7.70M$7.70M2016Revenue (USD)2025Fiscal YearRevenueChange YoY2025$7.70M+640.7%2024$1.04M-74.1%2023$4.01M—2022$0—2021$0-100.0%2020$71.0K-94.0%2019$1.19M-50.9%2018$2.43M+18.7%2017$2.04M+247.2%2016$589.0K—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share